Min Xie

7PUBLICATIONS
28CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityPharmaceutical delivery technologiesMedical mycologyRehabilitation engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 12, 2026
BCG vaccination with adjunctive APRIL immunotherapy reduces tuberculosis relapse in mice.

|Apr 28, 2026
Interstitial and recruited macrophages prevent tuberculosis relapse by limiting immune evasion.

|Jun 04, 2025
The Kinetics of Bedaquiline Diffusion in Tuberculous Cavities Open a Window for the Emergence of Resistance.

Annamarie E Bustion, Jacqueline P Ernest, Firat Kaya

|Sep 30, 2024
Spectinamide MBX-4888A exhibits favorable lesion and tissue distribution and promotes treatment shortening in advanced murine models of tuberculosis.

Allison A Bauman, Jansy P Sarathy, Firat Kaya

|Aug 24, 2024
Dose optimization of TBI-223 for enhanced therapeutic benefit compared to linezolid in antituberculosis regimen.

Natasha Strydom, Jacqueline P Ernest, Marjorie Imperial

|Jul 26, 2023
Wild mouse gut microbiota limits initial tuberculosis infection in BALB/c mice.

Min Xie, Chen-Yu Tsai, Zachary L McAdams

Pageof 2

Frequent Collaborators

5 joint publications

Martin Gengenbacher

3 joint publications

Jansy Sarathy

3 joint publications

Véronique Dartois

2 joint publications

Sabine Ehrt